Morphine dependence protects rat kidney against ischaemia-reperfusion injury

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 10, 2008, Pages 1209-1214

  Habibey, Rouhollah ^a   Pazoki Toroudi, Hamidreza ^b  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Nano Vichar Pharmaceutical Ltd   (Iran)

Author keywords

Creatinine clearance; Fractional excretion of sodium; Ischaemia reperfusion; Ischaemic preconditioning; Morphine dependence

Indexed keywords

MORPHINE; NALOXONE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DRUG DOSE INCREASE; DRUG MECHANISM; HISTOPATHOLOGY; ISCHEMIC PRECONDITIONING; KIDNEY INJURY; KIDNEY ISCHEMIA; MALE; MORPHINE ADDICTION; NONHUMAN; RAT; RENAL PROTECTION; REPERFUSION INJURY; SODIUM BLOOD LEVEL; SODIUM EXCRETION; SODIUM URINE LEVEL; UREA NITROGEN BLOOD LEVEL; URINE VOLUME; WISTAR RAT;

ANIMALS; DRUG ADMINISTRATION SCHEDULE; INJECTIONS, SUBCUTANEOUS; ISCHEMIC PRECONDITIONING; KIDNEY; MALE; MORPHINE; MORPHINE DEPENDENCE; RATS; RATS, WISTAR; RECEPTORS, OPIOID; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 50649091146     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.04986.x     Document Type: Article

References (41)

1. Schultz JE, Rose E, Yao Z, Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am. J. Physiol. 1995 268 : H2157 61.
2. Romano MA, Seymour EM, Berry JA, McNish RA, Bolling SF. Relative contribution of endogenous opioids to myocardial ischemic tolerance. J. Surg. Res. 2004 118 : 32 7.
3. Peart JN, Gross GJ. Exogenous activation of delta- and kappa-opioid receptors affords cardioprotection in isolated murine heart. Basic Res. Cardiol. 2004 99 : 29 37.
4. Okubo S, Tanabe Y, Takeda K et al. Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: Role of delta-opioid receptor. Am. J. Physiol. Heart Circ. Physiol. 2004 287 : H1786 91.
5. Cohen MV, Yang XM, Liu GS, Heusch G, Downey JM. Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ. Res. 2001 89 : 273 8.
6. Patel HH, Ludwig LM, Fryer RM, Hsu AK, Warltier DC, Gross GJ. Delta opioid agonists and volatile anesthetics facilitate cardioprotection via potentiation of K(ATP) channel opening. FASEB J. 2002 16 : 1468 70.
7. Zhang Y, Wu YX, Hao YB, Dun Y, Yang SP. Role of endogenous opioid peptides in protection of ischemic preconditioning in rat small intestine. Life Sci. 2001 68 : 1013 19.
8. 5] enkephalin (DADLE) protects liver against ischemia-reperfusion injury in the rat. J. Surg. Res. 2003 114 : 72 7.
9. Addison PD, Neligan PC, Ashrafpour H et al. Noninvasive remote ischemic preconditioning for global protection of skeletal muscle against infarction. Am. J. Physiol. Heart Circ. Physiol. 2003 285 : H1435 43.
10. Zhao P, Huang Y, Zuo Z. Opioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats. J. Neuropathol. Exp. Neurol. 2006 65 : 945 52.
11. Cochrane J, Williams BT, Banerjee A et al. Ischemic preconditioning attenuates functional, metabolic, and morphologic injury from ischemic acute renal failure in the rat. Renal Fail. 1999 21 : 135 45.
12. Lee HT, Emala CW. Protective effects of renal ischemic preconditioning and adenosine pretreatment: Role of A(1) and A(3) receptors. Am. J. Physiol. Renal Physiol. 2000 278 : F380 7.
13. Ogawa T, Mimura Y, Hiki N, Kanauchi H, Kaminishi M. Ischaemic preconditioning ameliorates functional disturbance and impaired renal perfusion in rat ischaemia-reperfused kidneys. Clin. Exp. Pharmacol. Physiol. 2000 27 : 997 1001.
14. Lee HT, Emala CW. Preconditioning and adenosine protect human proximal tubule cells in an in vitro model of ischemic injury. J. Am. Soc. Nephrol. 2002 13 : 2753 61.
15. Lee HT, Xu H, Ota-Setlik A, Emala CW. Oxidant preconditioning protects human proximal tubular cells against lethal oxidant injury via p38 MAPK and heme oxygenase-1. Am. J. Nephrol. 2003 23 : 324 33.
16. Park KM, Chen A, Bonventre JV. Prevention of kidney ischemia/reperfusion- induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J. Biol. Chem. 2001 276 : 11870 6.
17. Lee HT, Emala CW. Protein kinase C and G(i/o) proteins are involved in adenosine- and ischemic preconditioning-mediated renal protection. J. Am. Soc. Nephrol. 2001 12 : 233 40.
18. Joo JD, Kim M, D'Agati VD, Lee HT. Ischemic preconditioning provides both acute and delayed protection against renal ischemia and reperfusion injury in mice. J. Am. Soc. Nephrol. 2006 17 : 3115 23.
19. Peart JN, Gross GJ. Morphine-tolerant mice exhibit a profound and persistent cardioprotective phenotype. Circulation 2004 109 : 1219 22.
20. Peart JN, Gross GJ. Chronic exposure to morphine produces a marked cardioprotective phenotype in aged mouse hearts. Exp. Gerontol. 2004 39 : 1021 6.
21. Peart JN, Gross GJ. Cardioprotective effects of acute and chronic opioid treatment are mediated via different signaling pathways. Am. J. Physiol. Heart Circ. Physiol. 2006 291 : H1746 53.
22. Wittert G, Hope P, Pyle D. Tissue distribution of opioid receptor gene expression in the rat. Biochem. Biophys. Res. Commun. 1996 218 : 877 81.
23. 5]-enkephalinamide and antiserum to methionine-enkephalin microinjected into the caudal periaqueductal gray on morphine withdrawal in rats. Jpn. J. Pharmacol. 1998 78 : 455 61.
24. Kapusta DR, Obih JC, Dibona GF. Central mu opioid receptor-mediated changes in renal function in conscious rats. J. Pharmacol. Exp. Ther. 1993 265 : 134 43.
25. Kapusta DR, Sezen SF, Chang JK, Lippton H, Kenigs VA. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Life Sci. 1997 60 : PL15 21.
26. Ko WW, Dai S, Chan MY. Cardiovascular responses to acute myocardial ischaemia in morphine-dependent rats. Clin. Exp. Pharmacol. Physiol. 1988 15 : 23 31.
27. Joo JD, Kim M, Horst P et al. Acute and delayed renal protection against renal ischemia and reperfusion injury with A1 adenosine receptors. Am. J. Physiol. Renal Physiol. 2007 293 : F1847 57.
28. Gross GJ. Role of opioids in acute and delayed preconditioning. J. Mol. Cell Cardiol. 2003 35 : 709 18.
29. Patel HH, Hsu A, Moore J, Gross GJ. BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation. J. Mol. Cell Cardiol. 2001 33 : 1455 65.
30. ATP channels. Circ. Res. 1999 84 : 846 51.
31. Frässdorf J, Weber NC, Obal D et al. Morphine induces late cardioprotection in rat hearts in vivo: The involvement of opioid receptors and nuclear transcription factor kappaB. Anesth. Analg. 2005 101 : 934 41.
32. ATP channel linked mechanisms in rats. Br. J. Anaesth. 2000 84 : 204 14.
33. Peart JN, Gross GJ. Adenosine and opioid receptor-mediated cardioprotection in the rat: Evidence for cross-talk between receptors. Am. J. Physiol. Heart Circ. Physiol. 2003 285 : H81 9.
34. Halimi G, Devaux C, Clot-Faybesse O et al. Modulation of adenosine concentration by opioid receptor agonists in rat striatum. Eur. J. Pharmacol. 2000 398 : 217 24.
35. Eisenach JC, Hood DD, Curry R, Sawynok J, Yaksh TL, Li X. Intrathecal but not intravenous opioids release adenosine from the spinal cord. J. Pain 2004 5 : 64 8.
36. Brundege JM, Williams JT. Increase in adenosine sensitivity in the nucleus accumbens following chronic morphine treatment. J. Neurophysiol. 2002 87 : 1369 75.
37. Sugino H, Shimada H, Tsuchimoto K. Role of adenosine in renal protection induced by a brief episode of ischemic preconditioning in rats. Jpn. J. Pharmacol. 2001 87 : 134 42.
38. Blaszczyk J, Kedziora J, Luciak M, Sibiñska E, Trznadel K, Pawlicki L. Effect of morphine and naloxone on oxidative metabolism during experimental renal ischemia and reperfusion. Exp. Nephrol. 1994 2 : 364 70.
39. Wang TL, Chang H, Hung CR, Tseng YZ. Morphine preconditioning attenuates neutrophil activation in rat models of myocardial infarction. Cardiovasc. Res. 1998 40 : 557 63.
40. Weed MR, Carruth LM, Adams RJ, Ator NA, Hienz RD. Morphine withdrawal dramatically reduces lymphocytes in morphine-dependent macaques. J. Neuroimmune Pharmacol. 2006 1 : 250 9.
41. Clark JD, Shi X, Li X et al. Morphine reduces local cytokine expression and neutrophil infiltration after incision. Mol. Pain 2007 3 : 28.